Balazs AB, Bloom JD, Hong CM, Rao DS, Baltimore D. Broad protection
against influenza infection by vectored immunoprophylaxis in mice.
Higher levels of HA antibodies in a person's body have long been associated with greater protection
against influenza infection.
Not exact matches
Respond better to immunizations
against Polio, Tetanus, Diphtheria, and Haemophilus
influenza (bacterium that can cause a severe
infection)
The Hep B vaccine (or HBV) protects
against the virus that causes hepatitis B; the DTaP vaccine protects
against the viruses that cause diphtheria, tetanus, and pertussis (whooping cough); the PCV (pneumococcal vaccine) protects
against the cause of bacterial meningitis, pneumonia, and ear
infections; the Hib vaccine protects
against Haemophilus
influenzae type b bacteria (which can also cause bacterial meningitis, pneumonia, or epiglottitis); and the rotavirus oral vaccine protects
against a virus that causes the stomach flu.
Public Health Thank You Day 2013 honors all those health heroes who keep our drinking water safe and air clean, administer vaccines, track and investigate
infections, educate residents with chronic diseases such as asthma and diabetes, provide cancer screening services, administer pest control programs and protect us
against imminent threats to our health such as
influenza, foodborne illnesses and natural disasters.
Vaccinating pregnant mothers year - round
against flu in the resource - challenged region of subtropical Nepal reduced infant flu virus
infection rates by an average of 30 percent, increased birth weights by 15 percent and resulted in babies having less
influenza, according to a study published in The Lancet Infectious Diseases.
«We found that the vaccines produced
against the swine flu pandemic in 2009 were very effective in both preventing
influenza infection and reducing the chances of hospital admission due to flu.
New Scientist echoed the point in an editorial: «If the purpose of the Microbiological Research Establishment is to learn to make vaccines and devise other measures to protect the country
against man - made epidemics — just as we try to protect ourselves
against influenza or measles — then there is every reason to bring the establishment under the Ministry of Health» («Porton — the
infection spreads», 30 May 1968).
Currently, seasonal flu vaccines are designed to induce high levels of protective antibodies
against hemagglutinin (HA), a protein found on the surface of the
influenza virus that enables the virus to enter a human cell and initiate
infection.
Since the most severe
infections are caused by
influenza type A and type B viruses, the available vaccines provide coverage
against these two types.
Guidelines recommend that vaccinations should be used to protect
against certain
infections, such as
influenza and pneumonia.
The vaccine lowers
infection risk — it works very well
against influenza B — and may also minimize the risk of severe
infection.
According to WHO statistics, 300 million people are vaccinated
against the flu each year, receiving an immunization with a cocktail of weakened strains of
influenza A (varieties H3N2 and H1N1), along with the
influenza B virus to protect
against a full
infection.
The article «Hybrid inorganic - organic capsules for efficient intracellular delivery of novel siRNAs
against influenza A (H1N1) virus
infection» was published in Scientific Reports.
Scientists from Tomsk Polytechnic University together with their colleagues from St. Petersburg and London have elaborated a new approach to deliver anti-viral RNAi to target cells
against H1N1
influenza virus
infection.
Three types of siRNA
against influenza A (H1N1) virus
infection were encapsulated in hybrid carriers.
«Our findings suggest that different prostaglandins have different roles in antiviral immunity and that specific inhibition of PGE2 will be an effective therapy
against influenza viral
infection by boosting immune responses.»
Unlike antibodies elicited by annual
influenza vaccinations, most neutralizing antibodies induced by pandemic H1N1
infection were broadly cross-reactive
against epitopes in the hemagglutinin (HA) stalk and head domain of multiple
influenza strains.
Broadly cross-reactive antibodies dominate the human B cell response
against 2009 pandemic H1N1
influenza virus
infection
In the search for drugs that act broadly
against different
influenza strains, researchers had previously shown that antibodies
against the HA stem region can prevent
influenza infection.
MxA is therefore a barrier
against cross-species
influenza A
infection, but one that the virus can evade through a few mutations in its nucleoprotein.
She noted that the Canadian researchers estimated that the flu vaccine is 55 percent effective
against influenza B viruses, which typically cause more
infections late in the season.
The results showed that elderberry syrup is also effective
against both
influenza A and B virus
infections.
Vaccination
against other pathogens causing respiratory disease may help prevent more common respiratory pathogens from becoming secondary
infections in a respiratory tract already compromised by
influenza infection.
Make sure you inquire about vaccination
against Canine
Influenza, a viral respiratory tract
infection.
According to the American Veterinary Medical Association, «Currently, there is no USDA - licensed vaccine
against H5N1 highly pathogenic avian
influenza infection available for use in companion animals in the United States.»
Vaccination
against other pathogens causing respiratory disease (such as Bordetella, adenovirus and parainfluenza) may help prevent more common respiratory pathogens from becoming secondary
infections in a respiratory tract already compromised by
influenza infection.
Vaccines
against other respiratory causing pathogens, such as Bordetella, parainfluenza, and adenovirus, may help to prevent a secondary
infection in a dog already compromised by the
influenza virus.
Canine
Influenza Vaccine H3N8 protects against this influenza, a highly contagious respiratory i
Influenza Vaccine H3N8 protects
against this
influenza, a highly contagious respiratory i
influenza, a highly contagious respiratory
infection.
Feline Herpesvirus and Feline Calicivirus Feline Herpesvirus (causative agent of Feline Infectious Rhinotracheitis) and Feline Calicivirus (causative agent of Feline
Influenza) are two of the three feline respiratory
infections against which the feline 3 - in - 1 vaccine protects.
These pollutants cause lung irritation and weaken the body's defenses
against respiratory
infections such as pneumonia and
influenza.
The majority of antibodies that prevent
influenza virus
infection are directed
against HA.